Cathie Wood started to build up the position in Ginkgo Bioworks Holdings in Q3 2021 and continued to invest until Q4 2023. Since then they sold 4.97 Million shares. The investor completely sold their stake between Q1 2024 and Q3 2024.
Avg closing price
Price range
Sold -596 Thousand shares
Q3 2024
Avg closing price
$9.97
Price range
$5.36
-
$15.20
Sold 87.4% shares (-4.14 Million shares)
Q2 2024
Avg closing price
$0.75
Price range
$0.28
-
$1.16
Sold 4.5% shares (-225 Thousand shares)
Q1 2024
Avg closing price
$1.29
Price range
$1.06
-
$1.67
Increased shares by 9.0% (+410 Thousand shares)
Q4 2023
Avg closing price
$1.53
Price range
$1.26
-
$1.79
Increased shares by 7.3% (+311 Thousand shares)
Q3 2023
Avg closing price
$2.00
Price range
$1.61
-
$2.54
Increased shares by 3.0% (+125 Thousand shares)
Q2 2023
Avg closing price
$1.48
Price range
$1.14
-
$1.95
Increased shares by 14.1% (+509 Thousand shares)
Q1 2023
Avg closing price
$1.58
Price range
$1.20
-
$2.19
Increased shares by 13.9% (+439 Thousand shares)
Q4 2022
Avg closing price
$2.30
Price range
$1.63
-
$3.52
Increased shares by 45.2% (+987 Thousand shares)
Q3 2022
Avg closing price
$2.98
Price range
$2.38
-
$3.74
Increased shares by 35.4% (+571 Thousand shares)
Q2 2022
Avg closing price
$3.05
Price range
$2.20
-
$4.20
Increased shares by 49.4% (+534 Thousand shares)
Q1 2022
Avg closing price
$4.87
Price range
$2.83
-
$8.69
Increased shares by 85.9% (+499 Thousand shares)
Q4 2021